Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. - Wikidata - wikimedia - TriplyDB

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

http://www.wikidata.org/entity/Q34322056

about

Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection Adrenergic regulation of innate immunity: a review Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair Anti-inflammatory therapy in chronic disease: challenges and opportunities Understanding the role of B cells in atherosclerosis: potential clinical implications Imaging and nanomedicine in inflammatory atherosclerosis Cardiomyocytes induce macrophage receptor shedding to suppress phagocytosis Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity.Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.Nonclassical patrolling monocyte function in the vasculature Cholesterol, inflammation and innate immunity PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation Lp-PLA2 Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages Immune cell screening of a nanoparticle library improves atherosclerosis therapy Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension Inflammation-a Critical Appreciation of the Role of Myeloid Cells Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver Bioinspired Microfluidic Assay for In Vitro Modeling of Leukocyte–Endothelium Interactions Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid Imaging systemic inflammatory networks in ischemic heart disease Circadian Influence on Metabolism and Inflammation in Atherosclerosis.Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus β-mannosyl linkages inhibit CAWS arteritis by negatively regulating dectin-2-dependent signaling in spleen and dendritic cells.Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis Cholesterol and hematopoietic stem cells: inflammatory mediators of atherosclerosis.Neutrophil stunning by metoprolol reduces infarct size Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium.Androgen activity and markers of inflammation among men in NHANES III Macrophage polarization in inflammatory diseases.Towards a molecular systems model of coronary artery disease Chronic variable stress activates hematopoietic stem cells.Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly.Cardiovascular involvement in autoimmune diseases.Anti-inflammatory therapies for cardiovascular disease

P2860

Q24314350-065FC3AB-A65D-4DE7-B30F-5FA40613B8BA Q26747421-015B25DC-D336-4F0F-A1B9-9C6867A02AF1 Q26748869-529063EB-BC65-4930-B9A2-EB4B826D2A8E Q26770209-8304503E-F6ED-4F41-95F4-395408CBD117 Q26796227-031F1FAE-DF1E-4CAE-8E71-96098B987441 Q26852506-883D5A67-E439-4702-BB1A-D83D0DE9D57E Q26860162-E7A516DE-6235-48A0-8179-5904A8123F14 Q26991813-F2E2D67E-8239-44B0-8923-FCA3867D8D63 Q27002916-C463A7BD-A38B-4DC5-9358-2B12B2B7FE42 Q27302322-862D9D93-31B9-4459-97D1-DF0A6AA05E6E Q27693855-549ADE13-1069-48CA-997F-94EF07A8CD48 Q28072367-61BE41AE-69DD-4525-AECF-C2F86FEB618B Q28080570-3BCEDE6B-48A3-4C71-9680-CA09B84A4506 Q28086912-BFE08258-BAF7-4E62-A134-EF3B2AC2557C Q28314913-59EBD0E0-9DFD-4A6D-BA5D-A536C3379656 Q28388609-1832476C-3A2C-42F3-932D-0316B558F842 Q28393434-21A7297A-280C-4F63-8F9A-FB91413E7769 Q28541982-A759ECB5-A213-4256-9589-B9E7D2840280 Q28595434-25C7DFA9-35BC-4807-9BCF-307C7C9A2AB4 Q29248143-CF7C8C4A-293B-419F-AB55-317B07CBE1A8 Q29393220-42426252-7950-42E2-A452-D8A7EEA4E73F Q30248988-902F1BBF-FD96-47AD-932D-BC8863BF1189 Q30316648-525D7E83-62CE-4725-8C75-A02A4A47EB64 Q30389726-92F80C41-E1BF-4376-9302-9E7A81621AD6 Q30587267-BB2D3000-D6AE-4BF8-ABB8-34DD8011CED0 Q30663632-BD8BE662-E508-477F-8417-67B0C65162D1 Q30711427-A7CABFE1-A122-48EB-8C1E-C4F07A5BC3B5 Q30870962-2C022F76-9F36-4A9C-9142-40B1043AC1EE Q31133829-F55689C0-0F16-4B68-9342-429FB6ED0354 Q33552022-B783A3C0-588D-4CD7-AD69-1E1D2230BFD2 Q33587119-3E8CD645-6136-4B35-9868-49AC0B74D87C Q33596007-B9C423EB-258E-4CEB-939F-DB313D4BFC32 Q33647847-027A6B29-A584-4A0D-B26C-8A8D9352D315 Q33716370-6F3BFB2F-6CC7-4030-9BDB-6B27B592ECD3 Q33729494-7563F014-8E53-4239-8F5E-845F2C129110 Q33864613-1FF54971-5699-4A87-899F-D901297A69B5 Q33949943-DC517CF2-58AD-4DCE-925B-E9DBEEF016DF Q34020484-B0082FAF-58BF-45CC-A8B2-8A16EDA51559 Q34081242-CD77EEF1-43D0-483D-92F0-076EF7418703 Q34137872-1F21AC5A-E44E-4A40-B0B2-0313C11F28AC

P2860

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

http://www.wikidata.org/entity/Q34322056

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@ast

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@en

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@nl

type

label

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@ast

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@en

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@nl

prefLabel

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@ast

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@en

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@nl

P1433

Q34322056-6E764A42-E38A-4A9B-AB3B-10E272B830A8

P1476

Q34322056-69E8201B-7321-4D92-B3F6-7749B3735582

P2093

Q34322056-D79BC0D7-A3A5-482D-9D7F-9215C809E484

P2860

Q34322056-016BFFEC-4428-4963-BDB3-A94703BEED9F

Q34322056-0450E385-8561-4E29-98C7-DF4B596B44E7

Q34322056-090FAEDC-A27C-4CB6-882E-D601D2F3431D

Q34322056-0FA39DE2-0684-4A14-BEDA-D4BE2A6E22A9

Q34322056-10293C60-0CFD-4EAE-9A5B-680A3C44F425

Q34322056-142EBA7F-48F3-46F0-B53F-672C31F02BF5

Q34322056-2A12FD2E-2FF3-431C-A008-80F6509C3C53

Q34322056-2D9B26F2-211A-45CE-8BA2-29E6BE45CB2C

Q34322056-2F0C016A-E8C5-4572-94B4-D25FCCDB4BAB

Q34322056-3858A479-4EDE-4DAE-8100-3201C073D82E

P304

Q34322056-20D64BCE-72A8-41C7-A764-A490DA17EFAA

P31

Q34322056-FBBCBCBB-9006-4356-8AE4-CB2F31BDC14A

P356

Q34322056-68E8BCBC-24B7-47DF-9555-C73F5545551F

P407

Q34322056-6C4DEF49-7830-4E46-8F90-7DD3B9428B04

P433

Q34322056-5D0728F7-F2F1-453F-8C1D-92C78AA565D2

P478

Q34322056-44867405-5BAB-49F8-AF01-7B9E9D9629BB

P50

Q34322056-97F3079D-7682-4D64-84CA-E4AD9204F35A

P577

Q34322056-D59ACE64-A0DA-49DF-856E-D763D51AED16

P698

Q34322056-4E4D9884-99A3-4F32-A4A6-3E15E77355C4

P921

Q34322056-12C38E3E-B047-468B-8685-875D823B2D4F

Q34322056-8888525E-24D7-49AF-9973-F3E8FC32785A

Q34322056-D73980BB-7818-4109-AA27-1E61CC7D74E7

P932

Q34322056-05728B0B-EE8B-4864-AE65-D290C1739F45

P356

SCIENCE.1230719

P1433

P1476

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.

@en

P2093

Matthias Nahrendorf

http://www.w3.org/2001/XMLSchema#string

P2860

Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Development of monocytes, macrophages, and dendritic cells

Macrophages in the pathogenesis of atherosclerosis

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.

P304

161-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1230719

http://www.w3.org/2001/XMLSchema#string

P407

P433

6116

http://www.w3.org/2001/XMLSchema#string

P478

339

http://www.w3.org/2001/XMLSchema#string

P50

Filip K Swirski

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23307733

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3891792

http://www.w3.org/2001/XMLSchema#string